06:30 AM EST, 02/18/2025 (MT Newswires) -- Oncolytics Biotech ( ONCY ) , a clinical-stage company specializing in immunotherapy for oncology, over the holiday weekend said it received a delinquency notification letter from the The Nasdaq Stock Market on February 13.

A statement said the notice indicated the company was not, at that time, in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing as the closing bid price for the company's ordinary shares was below US$1.00 for 30 consecutive business days.

The company has 180 days from the date of the notice, or until August 12, to regain compliance with the minimum bid price requirement. On Friday, the shares closed down 0.6% at 0.7672.